- Home
- SLNO vs DKL Comparison
SLNO vs DKL Comparison
Compare SLNO & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- DKL
- Stock Information
- Founded
- SLNO 1999
- DKL 2012
- Country
- SLNO United States
- DKL United States
- Employees
- SLNO N/A
- DKL N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- DKL Natural Gas Distribution
- Sector
- SLNO Health Care
- DKL Energy
- Exchange
- SLNO Nasdaq
- DKL Nasdaq
- Market Cap
- SLNO 2.3B
- DKL 2.3B
- IPO Year
- SLNO 2014
- DKL N/A
- Fundamental
- Price
- SLNO $71.99
- DKL $43.63
- Analyst Decision
- SLNO Strong Buy
- DKL Buy
- Analyst Count
- SLNO 8
- DKL 4
- Target Price
- SLNO $92.00
- DKL $44.25
- AVG Volume (30 Days)
- SLNO 1.8M
- DKL 207.8K
- Earning Date
- SLNO 05-08-2025
- DKL 05-06-2025
- Dividend Yield
- SLNO N/A
- DKL 10.00%
- EPS Growth
- SLNO N/A
- DKL 3.46
- EPS
- SLNO N/A
- DKL 2.99
- Revenue
- SLNO N/A
- DKL $940,636,000.00
- Revenue This Year
- SLNO N/A
- DKL $13.75
- Revenue Next Year
- SLNO N/A
- DKL N/A
- P/E Ratio
- SLNO N/A
- DKL $14.60
- Revenue Growth
- SLNO N/A
- DKL N/A
- 52 Week Low
- SLNO $36.61
- DKL $37.02
- 52 Week High
- SLNO $73.97
- DKL $45.71
- Technical
- Relative Strength Index (RSI)
- SLNO 84.44
- DKL 61.78
- Support Level
- SLNO $48.29
- DKL $42.41
- Resistance Level
- SLNO $51.88
- DKL $44.23
- Average True Range (ATR)
- SLNO 3.03
- DKL 0.83
- MACD
- SLNO 2.32
- DKL 0.22
- Stochastic Oscillator
- SLNO 93.61
- DKL 84.73
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests
Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.